advisorsecurities master

CLNNClene Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
13482
Ticker
CLNN
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-12-31
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
CLNN

Detail

Enriched 2026-08-14 20:47

Market cap
$52,007,709.49
Shares outstanding (class)
12,778,307
Shares outstanding (weighted)
12,778,307
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
79
Location
SALT LAKE CITY, UT
Description

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data